Financhill
Back

Bristol-Myers Squibb Vs. Neurogene Industry Stock Comparison

Sell
43

BMY
Bristol-Myers Squibb

Last Price:
55.46
Seasonality Move:
1.69%
Buy
75

NGNE
Neurogene

Last Price:
61.10
Seasonality Move:
58.98%
Sell
43
Bristol-Myers Squibb (BMY) is a Sell

Is Bristol-Myers Squibb a Buy, Sell or Hold?

  • The current Bristol-Myers Squibb [BMY] share price is $55.45. The Score for BMY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • BMY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Neurogene (NGNE) is a Buy

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $66.00. The Score for NGNE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • NGNE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BMY Stock Price Chart

What is Bristol-Myers Squibb's stock price today?

  • The Bristol-Myers Squibb share price today is $55.45
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $66.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NGNE is experiencing slight buying pressure.

BMY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.87 Buy
Relative Strength Index (14 RSI): 63.78 Buy
Chaikin Money Flow: 6017710 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.14 - 54.1) Buy
Bollinger Bands (100): (43.28 - 52.28) Buy

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.06 Buy
Relative Strength Index (14 RSI): 75.97 Buy
Chaikin Money Flow: 176225 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.28 - 53.36) Buy
Bollinger Bands (100): (34.64 - 46.72) Buy

BMY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.52 Buy
20-day SMA: 53.07 Buy
50-day SMA: 51.27 Buy
200-day SMA: 47.96 Buy
8-day EMA: 53.96 Buy
20-day EMA: 53.1 Buy
50-day EMA: 51.36 Buy
200-day EMA: 49.82 Buy

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.43 Buy
20-day SMA: 49.56 Buy
50-day SMA: 43.32 Buy
200-day SMA: 37.93 Buy
8-day EMA: 50.65 Buy
20-day EMA: 48.54 Buy
50-day EMA: 44.96 Buy
200-day EMA: 36.96 Buy

Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.54 per share, and an increase next year of $6.19 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.

Bristol-Myers Squibb Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):